Phosphorylation of tumour suppressor Amotl2 by IKBKE kinase promotes YAP1 signalling, enhancing glioblastoma growth.
Overview
- Department of Neurosurgery, Henan Provincial People,s Hospital; Zhengzhou University People,s Hospital; Cerebrovascular Disease Hospital, Zhengzhou, Henan, China
- Tianjin Neurological Institute, Key Laboratory of Post-Neuroinjury Neuro-repair and Regeneration in Central Nervous System, Ministry of Education and Tianjin City, Tianjin Medical University General Hospital, Tianjin, China
- Department of Neurosurgery, Yantai Yuhuangding Hospital, Yantai, Shandong, China
Abstract
Inhibitor of nuclear factor kappa-B kinase subunit epsilon (IKBKE), a member of the serine/
Reproduced under the paper's license (CC BY), from the paper cited above.
Code
The paper links to its data and to no code of its authors: see the Data section.
Tracing map
A tracing map links a paper to the code its authors published: this paper has none, so it has no map.
Data
Datasets cited
- geo:GSE16011, at NCBI GEO; found in the text, “Online databases”
Data availability statement
The raw data supporting the conclusions of this article will be made available by the authors, without undue reservation.
Reproduced under the paper's license (CC BY), from the paper cited above.
Versions
The history of this record: each version stored by the harvester or made by a correction of its authors or of the maintainers of its code, and what changed in its facts. The texts of the paper (its abstract, its availability statements) are not part of it; versions that changed only those are not listed.
Version 2, 28 September 2026
- Funding: added National Natural Science Foundation of China: 81572490; Tianjin Medical University: 300052
Version 1, 27 September 2026: the first record
Recorded: type, language, journal, volume, pages, dates, 9 authors, 5 keywords, 43 references.
Cite
This paper
Guo, G., Sun, Y., Hong, R., Lu, Y., Chen, X., Zhao, L., Li, C., Liu, Y., & Huang, Q. (2026). Phosphorylation of tumour suppressor Amotl2 by IKBKE kinase promotes YAP1 signalling, enhancing glioblastoma growth. Frontiers in oncology, 16, 1823895. https://
BibTeX
@article{guo2026phosphor
author = {Guo, Gaochao and Sun, Yan and Hong, Rujun and Lu, Yalin and Chen, Xingjie and Zhao, Liming and Li, Chaoyue and Liu, Yang and Huang, Qiang},
title = {{Phosphorylation of tumour suppressor Amotl2 by IKBKE kinase promotes YAP1 signalling, enhancing glioblastoma growth}},
journal = {Frontiers in oncology},
year = {2026},
month = jul,
volume = {16},
pages = {1823895},
publisher = {Frontiers Media SA},
issn = {2234-943X},
doi = {10.3389/
url = {https://
pmid = {42568372},
pmcid = {PMC13447070}
}
RIS
TY - JOUR
AU - Guo, Gaochao
AU - Sun, Yan
AU - Hong, Rujun
AU - Lu, Yalin
AU - Chen, Xingjie
AU - Zhao, Liming
AU - Li, Chaoyue
AU - Liu, Yang
AU - Huang, Qiang
TI - Phosphorylation of tumour suppressor Amotl2 by IKBKE kinase promotes YAP1 signalling, enhancing glioblastoma growth
T2 - Frontiers in oncology
J2 - Front Oncol
PY - 2026
DA - 2026/
VL - 16
SP - 1823895
SN - 2234-943X
PB - Frontiers Media SA
DO - 10.3389/
UR - https://
LA - en
ER -
CSL-JSON
{
"id": "10.3389/
"type": "article-journal",
"title": "Phosphorylation of tumour suppressor Amotl2 by IKBKE kinase promotes YAP1 signalling, enhancing glioblastoma growth",
"container-title": "Frontiers in oncology",
"author": [
{
"family": "Guo",
"given": "Gaochao"
},
{
"family": "Sun",
"given": "Yan"
},
{
"family": "Hong",
"given": "Rujun"
},
{
"family": "Lu",
"given": "Yalin"
},
{
"family": "Chen",
"given": "Xingjie"
},
{
"family": "Zhao",
"given": "Liming"
},
{
"family": "Li",
"given": "Chaoyue"
},
{
"family": "Liu",
"given": "Yang"
},
{
"family": "Huang",
"given": "Qiang"
}
],
"container-title-short":
"volume": "16",
"page": "1823895",
"DOI": "10.3389/
"PMID": "42568372",
"PMCID": "PMC13447070",
"ISSN": "2234-943X",
"publisher": "Frontiers Media SA",
"URL": "https://
"language": "en",
"issued": {
"date-parts": [
[
2026,
7,
24
]
]
}
}
Similar papers
The papers with a page that share the most with this one: the tools found in their code, their categories, datasets, cited references and authors, the rarest counting most.
- [1] doi:10.3390/jcm11195863
- Glioma Shapes Blood-Brain Barrier Integrity and Remodels the Tumor Microenvironment: Links with Clinical Features and Prognosis.Journal: Journal of clinical medicineIn common: NCBI GEO GSE16011, other condition, 1 reference
- [2] doi:10.3389/fgene.2022.890174
- Identification of BST2 Contributing to the Development of Glioblastoma Based on Bioinformatics Analysis.Journal: Frontiers in geneticsIn common: NCBI GEO GSE16011, other condition, 1 reference
- [3] doi:10.18632/aging.204079
- Intra-tumoral angiogenesis correlates with immune features and prognosis in glioma.Journal: AgingIn common: NCBI GEO GSE16011, other condition, 1 reference
- [4] doi:10.1016/j.isci.2021.103249
- The clinical features, prognostic significance, and immune heterogeneity of CD37 in diffuse gliomas.Journal: iScienceIn common: NCBI GEO GSE16011, other condition, 1 reference
- [5] doi:10.3389/fimmu.2022.1018942
- Establishment and validation of a novel prognostic model for lower-grade glioma based on senescence-related genes.Journal: Frontiers in immunologyIn common: NCBI GEO GSE16011, other condition, 1 reference
- [6] doi:10.1007/s12672-025-04271-8
- Integrative analysis reveals NFIL3 as a prognostic marker in glioblastoma associated with anesthesia and circadian rhythm genes.Journal: Discover oncologyIn common: NCBI GEO GSE16011, other condition, 1 reference
- [7] doi:10.3390/ijms25053020
- Gene Expression of <i>CSF3R</
i>/ CD114 Is Associated with Poorer Patient Survival in Glioma. Journal: International journal of molecular sciencesIn common: NCBI GEO GSE16011, other condition, 1 reference - [8] doi:10.3389/fnmol.2022.913328
- Identification of Candidate Genes Associated With Prognosis in Glioblastoma.Journal: Frontiers in molecular neuroscienceIn common: NCBI GEO GSE16011, other condition, 1 reference
- [9] doi:10.21037/tcr-2025-1599
- The atypical kinase right open reading frame kinase 1 suppresses glioma cell growth through mammalian target of rapamycin inhibition and apoptotic signaling activation.Journal: Translational cancer researchIn common: NCBI GEO GSE16011, other condition, cellular / molecular
- [10] doi:10.1186/s13046-024-03019-6
- Tumor suppressor role of the complement inhibitor CSMD1 and its role in TNF-induced neuroinflammation in gliomas.Journal: Journal of experimental & clinical cancer research : CRIn common: NCBI GEO GSE16011, other condition, cellular / molecular
Contribute
The authors of this paper can claim it, correct its record and validate its tracing map, and the maintainers of its code (its owner, or a public member of its organization) correct what it says of their repository; anyone signed in can ask for its removal. Every request goes to OSCR's own machine, which answers it; your account page follows them.
Sign in with ORCID to claim this paper as one of its authors, correct its record or validate its tracing map: when the paper's metadata lists your ORCID iD, you are recognized at once. Maintainers of its code: sign in with GitHub, then claim the repository on your account page.
Claim this paper
Correct its record
Say what each link of this record is, remove the ones that are not the paper's, add the ones that are missing. The correction becomes a new version of the record, in its Versions section.
Request its removal
To ask OSCR to remove this record, the copies of its authors' scripts or its tracing map, use the removal request page: signed in, you say who you are, what to remove and why, then review and confirm the request. Published rules decide every request (how).
Discussion, reproductions, activity
Discussion: code errors and mismatches between the code and the paper about this paper and its code, from readers and its authors, beside the paper and its tracing map.
Reproductions: reports from readers who ran the authors' code and did not get the paper's result, what they ran, with which environment, commit and data.
Activity: what happens around this paper: new versions of its record, its map's validation, discussions and reproductions. It opens with sign-in.
